PhaseBio Pharmaceuticals Inc (PHASQ)

[vwlibra]

DSG Supports PhaseBio Pharmaceuticals with Unified Clinical Trial Software Platform for COVID-19 Trial

https://www.biospace.com/article/releases/dsg-supports-phasebio-pharmaceuticals-with-unified-clinical-trial-software-platform-for-covid-19-trial/

July 17, 2020 13:30 UTC



MALVERN, Pa.--(BUSINESS WIRE)-- DSG, Inc., a global leader of eClinical software solutions and services for the life sciences industry has successfully launched a COVID-19 study with PhaseBio Pharmaceuticals, Inc. for its potentially pivotal clinical trial evaluating PB1046 as a treatment for hospitalized COVID-19 patients who are at high risk for rapid clinical deterioration and acute respiratory distress syndrome (ARDS).